logo

For the Inventor, By the Inventor

Abingdon, United Kingdom

Adaptimmune Limited

Calculating rank
USPTO Granted Patents = 28

% Expired Patents = 7.1



Trademarks = 2

Forward Citations = 29

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Bent Karsten Jakobsen (11 out of 32 patents)

silverMedal Peter Eamon Molloy (10 out of 17 patents)

bronzeMedal Nicholas Tribble (7 out of 7 patents)

4.  William Lawrance (7 out of 7 patents)

5.  Eleanor Bagg (7 out of 7 patents)

6.  Yi Li (7 out of 24 patents)

7.  Jonathan Michael Boulter (5 out of 9 patents)

8.  Steven Mark Dunn (4 out of 9 patents)

9.  Annelise Brigitte Vuidepot (3 out of 8 patents)

10.  Garth Hamilton (2 out of 2 patents)

11.  Jonathan Silk (2 out of 2 patents)

12.  Claire Gueguen (2 out of 2 patents)

13.  Nicholas Pumphrey (2 out of 2 patents)

14.  Brian John Cameron (2 out of 2 patents)

15.  Bruno Laugel (2 out of 2 patents)


Core Competencies:
T Cell Modification
T Cell Receptors
Cancer Treatment
TCR Libraries
Immunosuppression Resistance
Transgene Expression
Peptide Binding
High Affinity Receptors
T Cell Display
Tumor Immunotherapy
Major Histocompatibility Complex
Vectors

28 patents:

1. 12746272 - METHOD OF TREATMENT OF CANCER OR TUMOUR (2026-09-29),
2. 12589151 - T Cell Modification (2026-03-31),
3. 12180261 - T cell receptors (2024-12-31),
4. 12180260 - T cell receptors (2024-12-31),
5. 12145990 - T cell modification and use thereof (2024-11-19),
6. 12060404 - T cell receptors (2024-08-13),
7. 11929151 - Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex (2024-03-12),
8. 11753456 - T cell receptors (2023-09-12),
9. 11725040 - T cell receptors (2023-08-15),
10. 11572400 - T cell receptors (2023-02-07),
11. 11286289 - T cell receptors (2022-03-29),
12. 11203627 - T cell receptors (2021-12-21),
13. 11124556 - TCR libraries (2021-09-21),
14. 11111301 - T cell modification and use thereof (2021-09-07),
15. 11084862 - T cell receptors (2021-08-10),
Company Overview
Adaptimmune Limited is a biotechnology company based in Abingdon, UK, specializing in the development of T-cell therapies for cancer treatment. The company focuses on harnessing the power of the immune system to create innovative therapies that target specific cancer cells, aiming to improve patient outcomes. Adaptimmune's research emphasizes the use of engineered T-cell receptors to enhance the body's natural ability to fight cancer, positioning it at the forefront of immuno-oncology advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Adaptimmune Limited USPTO Patent Assignee Logo
28 Patents

#9 in Abingdon

#637 in United Kingdom

#23,299 in the World

Abingdon, GB
Abingdon, United Kingdom

Adaptimmune Limited

Forward Citations = 29

27 inventors:

goldMedal Bent Karsten Jakobsen (11 out of 32 patents)

silverMedal Peter Eamon Molloy (10 out of 17 patents)

bronzeMedal Nicholas Tribble (7 out of 7 patents)

4.  William Lawrance (7 out of 7 patents)

5.  Eleanor Bagg (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adaptimmune Limited. Retrieved from https://idiyas.com/company/adaptimmune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…